Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN112830872A reveals a superior 3-step synthesis for 2,3,4-trihydroxybenzaldehyde. Achieve >99% purity and reduced waste for Benserazide production.
Patent CN120398902A reveals Lewis base catalyzed route for anti-tumor intermediates. Offers mild conditions and scalable supply chain solutions.
Patent CN105348172B details a green synthesis route for Apremilast intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103588721B reveals a copper-catalyzed one-pot synthesis for difluoro compounds offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110483289A details asymmetric Kumada coupling for chiral alkenoates. This method offers high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Patent CN1215045C discloses high-purity crystalline salts of 3,3-diphenylpropylamine derivatives, offering superior stability and bioavailability for urinary incontinence treatments.
Patent CN1075055C details a novel one-pot reduction of amino acids to amino alcohols using unactivated borohydrides, offering significant cost reduction and high chiral purity for pharmaceutical manufacturing.
Patent CN103194501B reveals enzymatic synthesis for high purity chiral amino acids. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Discover a novel preparation method for rosuvastatin calcium intermediates featuring mild conditions, high yield, and superior stereocontrol for reliable pharmaceutical manufacturing.
Patent CN120309607A details high-purity Venetoclax intermediate synthesis. Offers cost reduction and supply reliability for API manufacturing.
Patent CN112047933B discloses a novel quinazolinone USP7 inhibitor synthesis with high yield and mild conditions, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN112939911A reveals a novel chiral resolution process for L-Corey lactone intermediates, offering high optical purity and scalable manufacturing for prostaglandin synthesis.
Advanced synthesis of Pemetrexed disodium intermediate via amino protection strategy. Reduces impurities, lowers costs, and ensures reliable supply for oncology drug manufacturing.
Patent CN103360410A reveals a novel Ofloxacin preparation method using trimethylchlorosilane for dual protection, significantly improving yield and reducing impurities for pharmaceutical manufacturing.
Patent CN112939925A reveals a mild synthetic route for long-chain alkanoic acid derivatives, offering cost reduction and scalability for API manufacturing.
Patent CN119876067B reveals high-activity carbonyl reductase mutants for diltiazem intermediates, offering scalable biocatalytic solutions for pharmaceutical manufacturing.
Patent CN103483363A reveals a novel Cu-NHC catalyzed route for diverse chiral aminoboronic acids, offering high stereoselectivity and simplified manufacturing for API intermediates.
Novel copper-catalyzed synthesis patent CN120923413A offers high-purity pharmaceutical intermediates with reduced metal residue risks and scalable production capabilities.
Novel patent CN120795013A reveals high-purity isoxazole synthesis route enabling cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier capabilities.